SGI
Summit Global Investments Portfolio holdings
AUM
$1.7B
This Quarter Return
-2.7%
1 Year Return
+10.82%
3 Year Return
+50.75%
5 Year Return
+99.59%
10 Year Return
–
AUM
$1.5B
AUM Growth
+$1.5B
(-0.6%)
Cap. Flow
+$48M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
31.06%
Holding
629
New
112
Increased
194
Reduced
178
Closed
128
Top Buys
| 1 |
SGI US Large Cap Core ETF
SGLC
|
$22.3M |
| 2 |
Salesforce
CRM
|
$17.2M |
| 3 |
Archer Daniels Midland
ADM
|
$16.6M |
| 4 |
Colgate-Palmolive
CL
|
$14.6M |
| 5 |
Elevance Health
ELV
|
$12.8M |
Top Sells
| 1 |
Cisco
CSCO
|
$10.2M |
| 2 |
Bank of New York Mellon
BK
|
$9.36M |
| 3 |
Kimberly-Clark
KMB
|
$8.76M |
| 4 |
PGIM Ultra Short Bond ETF
PULS
|
$8.57M |
| 5 |
Incyte
INCY
|
$8.51M |
Sector Composition
| 1 | Healthcare | 14.41% |
| 2 | Technology | 11.31% |
| 3 | Financials | 10.07% |
| 4 | Consumer Staples | 8.55% |
| 5 | Consumer Discretionary | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cognizant
CTSH
$35.1B
| $4.22M | 0.28% |
62,264
+43,806
| +237% | +$2.97M |
|
77
Everest Group
EG
$14.6B
| $4.2M | 0.28% |
11,310
+1,944
| +21% | +$722K |
|
78
HSBC
HSBC
$224B
| $4.06M | 0.27% |
102,778
-2,199
| -2% | -$86.8K |
|
79
Coca-Cola
KO
$297B
| $3.98M | 0.27% |
71,078
-20,929
| -23% | -$1.17M |
|
80
Rollins
ROL
$27.3B
| $3.86M | 0.26% |
+103,305
| New | +$3.86M |
|
81
Kellanova
K
$27.5B
| $3.78M | 0.25% |
63,551
-36,851
| -37% | -$2.19M |
|
82
SBA Communications
SBAC
$21.4B
| $3.75M | 0.25% |
18,740
+17,540
| +1,462% | +$3.51M |
|
83
Accenture
ACN
$158B
| $3.7M | 0.25% |
12,045
-19,481
| -62% | -$5.98M |
|
84
Nike
NKE
$110B
| $3.68M | 0.24% |
38,450
+27,866
| +263% | +$2.66M |
|
85
SPDR Portfolio Long Term Treasury ETF
SPTL
$11.4B
| $3.66M | 0.24% |
139,986
-127,217
| -48% | -$3.33M |
|
86
Novartis
NVS
$248B
| $3.63M | 0.24% |
35,599
+3,960
| +13% | +$403K |
|
87
Mondelez International
MDLZ
$79.3B
| $3.6M | 0.24% |
51,891
-897
| -2% | -$62.2K |
|
88
Simon Property Group
SPG
$58.7B
| $3.6M | 0.24% |
33,302
+1,197
| +4% | +$129K |
|
89
Idexx Laboratories
IDXX
$50.7B
| $3.56M | 0.24% |
8,149
-6,483
| -44% | -$2.83M |
|
90
Nice
NICE
$8.48B
| $3.52M | 0.23% |
20,723
+1,352
| +7% | +$230K |
|
91
National Fuel Gas
NFG
$7.77B
| $3.49M | 0.23% |
67,178
+31,215
| +87% | +$1.62M |
|
92
TSMC
TSM
$1.2T
| $3.48M | 0.23% |
40,030
-4,253
| -10% | -$370K |
|
93
Synopsys
SNPS
$110B
| $3.47M | 0.23% |
7,550
+6,420
| +568% | +$2.95M |
|
94
Manhattan Associates
MANH
$12.5B
| $3.4M | 0.23% |
+17,218
| New | +$3.4M |
|
95
United Therapeutics
UTHR
$17.7B
| $3.39M | 0.23% |
+15,017
| New | +$3.39M |
|
96
Neurocrine Biosciences
NBIX
$13.5B
| $3.38M | 0.23% |
30,037
+406
| +1% | +$45.7K |
|
97
Chubb
CB
$111B
| $3.34M | 0.22% |
16,052
-205
| -1% | -$42.7K |
|
98
Fortis
FTS
$24.9B
| $3.31M | 0.22% |
87,156
+1,604
| +2% | +$60.9K |
|
99
Yum! Brands
YUM
$40.1B
| $3.25M | 0.22% |
25,998
-57,329
| -69% | -$7.16M |
|
100
Intuit
INTU
$187B
| $3.16M | 0.21% |
6,192
-16,424
| -73% | -$8.39M |
|